MYCORGEN

Welcome to the Brand page for “MYCORGEN”, which is offered here for Pharmaceuticals for use in the treatment of cardiovascular disorders, for stimulation of blood vessel growth and for gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “MYCORGEN” is believed to be currently owned by “COLLATERAL THERAPEUTICS, INC.”

Competing brands may differ in terms of their ingredients, formulations, and efficacy. MYCORGEN stands out for its focus on treating cardiovascular disorders, stimulating blood vessel growth, and gene therapy, which are unique and innovative approaches to healthcare.

Owner:	COLLATERAL THERAPEUTICS, INC. Owner Details
Description:	Pharmaceuticals for use in the treatment of cardiovascular disorders, for stimulation of blood vessel growth and for gene therapy;
Categories:	PHARMACEUTICALS USE